MODERNA MRNA VACCINE

Moderna mRNA mpox vaccine shows promising results in animal study

According to Jay Hooper, a virologist from the US Army Medical Research Institute for Infectious Diseases and the study's senior author, researchers aimed to find a "sweet spot" in mpox vaccines that balances high safety and efficacy. Current mpox vaccines, originally developed for smallpox, use a weakened live virus that limits their protective efficacy compared to older, potentially infectious vaccines.